Merck names new CEO
Frazier will succeed Richard Clark, who has served as Merck’s CEO since 2005 and will continue as chairman of the board. Merck said that Frazier has served as
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
StayinFront claims that EdgeRx delivers fully featured on-demand CRM and integrated analytics capabilities, while offering the flexibility to access the system online or offline. StayinFront EdgeRx includes everything